Scottish Government officials have had informal discussions with the manufacturer, Gilead Sciences, to provide early access to sacituzumab govitecan (Trodelvy ® ) on an individual patient case by case basis in line with standard processes for such circumstances before it is submitted to the Scottish Medicines Consortium for health technology assessment. S6W...